Chimie pharmaceutique avancée et drug design [ WFARM2501 ]
3.0 crédits ECTS
20.0 h + 10.0 h
Teacher(s) |
Labar Geoffray (compensates Lambert Didier) ;
Lambert Didier ;
Poupaert Jacques ;
Muccioli Giulio (coordinator) ;
|
Language |
French
|
Place of the course |
Bruxelles Woluwe
|
Prerequisites |
organic chemistry and medicinal chemistry
|
Main themes |
The teacher(s) will discuss first the different techniques allowing the discovery of novel therapeutic targets (lipidomic ' proteomic ' deorphanization), second the methods allowing the identification of hits for a given molecular target (high-throughput screening ; computer assisted de novo drug design); finally the strategies allowing to optimize a hit ('hit to lead') will be discussed (structures-activity relationships ; docking; ')
|
Aims |
At the end of the activity the student will be able to
-
Interpret, based on what was discussed in class, the results presented in a scientific paper dealing with the development of a novel drug
-
Suggest a strategy allowing to identify novel therapeutic targets
-
Suggest a strategy allowing to identify novel lead compounds for a given target (enzyme, receptor, ')
-
Suggest a strategy allowing to optimize the activity of a drug towards its target
|
Evaluation methods |
a written exam and a presentation of a case-study based on a scientific paper
|
Content |
-
Lipidomics applied to the discovery of novel targets
-
Exploring the proteome looking for novel targets : the enzymes ' the receptors
-
Proteins as therapeutic target
-
Determination of their 3D structure
-
Role of protein's 3D models in drug design
-
The interest of establishing structure-activity relationships in drug design
|
Cycle et année d'étude |
> Master [120] in Pharmacy
|
Faculty or entity in charge |
> FARM
|
<<< Page précédente